Morgan Stanley analyst Drew Ranieri maintains Haemonetics (NYSE:HAE) with a Equal-Weight and raises the price target from $84 to $88.
GE HealthCare, Cleveland-Cliffs And A Tech Stock On CNBC’s ‘Final Trades’
On CNBC’s "Halftime Report Final Trades," Josh Brown of Ritholtz Wealth Management said Arista Networks, Inc. (NYSE: ANET) is